The analysis compares the amount introduced with measured amounts recovered in collected samples, amounts transformed into metabolites, and material retained within the system. Concentration measurements are combined with the corresponding sample volumes to estimate each component. This accounting framework helps investigators determine whether the observed disposition of a compound is sufficiently explained by the measured data.
Concentration alone does not indicate the total amount present in a sample. Investigators use the measured concentration together with the sample volume to estimate the amount recovered in that matrix. Applying this calculation across blood, urine, feces, or other relevant matrices allows results to be compared on an amount basis, reducing the risk of misinterpreting concentration changes as disposition changes.
Following metabolites distinguishes material that remains as the administered compound from material that has been transformed. This distinction is important because recovery of the parent compound alone may not describe the full disposition of the dose. Metabolite measurements therefore support metabolite characterization and help connect observed sample findings with the compound’s overall handling in the body.
Sample selection depends on which aspects of the compound’s disposition investigators need to evaluate. Blood, urine, feces, and other relevant biological matrices can provide measurements of the administered compound and its metabolites. Combining data from multiple specimens allows investigators to estimate recovery and disposition more comprehensively than measurements from a single biological matrix.
Investigators begin by tracking the administered compound, collect relevant biological samples, and measure the concentrations of the compound and its metabolites. They then combine those measurements with sample volumes to estimate amounts recovered, transformed, or retained. Comparing these quantities provides a quantitative disposition profile that can be used in pharmacokinetic and absorption, distribution, metabolism, and excretion studies.
Results can inform dose selection, clarify which metabolites require characterization, and contribute to safety assessment. By showing how the body handles an administered drug, the analysis also supplies evidence relevant to pharmacokinetic and absorption, distribution, metabolism, and excretion evaluations. These findings may support regulatory decisions when investigators need a quantitative account of recovery and disposition.